Skip to content

The Use of Intra-articular Corticosteroid Injection to Treat Osteoarthritis of the Carpometacarpal Joint

Thumb Osteoarthritis | Osteoarthritis of the Carpometacarpal Joint

This randomized clinical trial (RCT) will evaluate 6-month outcomes following intra-articular injections for arthritis of the thumb carpometacarpal (CMC) joint by comparing corticosteroid plus local anesthetic versus saline (placebo) plus local anesthetic.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Participants must be 18 years old or older at recruitment
* Present clinical and radiographic signs of thumb CMC OA using the American College of Rheumatology (ACR) criteria for the classification of hand osteoarthritis.

Exclusion Criteria:

* History of inflammatory arthritis
* Previous steroid joint injection to either thumb CMC joint
* Pregnancy or breastfeeding
* Psychiatric illness
* Cognitive impairment, or health conditions that preclude informed consent or receiving the injection
* People who do not speak/read/understand English, have no fixed address or contact, or are unwilling to complete follow-ups

Study Location

Western Hand & Upper Limb Facility, Sturgeon Community Hospital
Western Hand & Upper Limb Facility, Sturgeon Community Hospital
St. Albert, Alberta
Canada

Contact Study Team

Primary Contact

Raelee Phillips

Study Sponsored By
University of Alberta
Participants Required
More Information
Study ID: NCT04177433